Related Experiment Video
Updated: May 15, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
Extensive hypertrophic lupus erythematosus: atypical presentation
Tarun Narang1, Meghna Sharma, Nigabh Gulati
1Department of Dermatology, Venereology and Leprology, Gian Sagar Medical College and Hospital, Patiala, Punjab, India.
This case study highlights a successful treatment for hypertrophic lupus erythematosus (HLE) using isotretinoin. The therapy effectively managed atypical and extensive HLE skin lesions, offering hope for difficult cases.
Area of Science:
- Dermatology
- Rheumatology
- Pathology
Background:
- Lupus erythematosus (LE) presents diverse clinical features, complicating a unified disease concept.
- Hypertrophic lupus erythematosus (HLE) is a distinct subtype with potential for diagnostic and therapeutic challenges.
- Long-standing HLE lesions carry a risk of developing squamous cell carcinoma.
Purpose of the Study:
- To report a case of hypertrophic lupus erythematosus with unusual morphology and widespread skin involvement.
- To demonstrate the efficacy of isotretinoin in treating refractory HLE.
- To emphasize the importance of vigilant clinical and histopathological follow-up for HLE.
Main Methods:
- Diagnosis of hypertrophic lupus erythematosus confirmed via histopathological examination.
- Treatment involved a combination therapy including isotretinoin and hydroxychloroquine.
- Clinical response assessed through lesion morphology and regression.
Main Results:
- The patient presented with atypical and extensive hypertrophic lupus erythematosus lesions.
- Combination therapy with isotretinoin and hydroxychloroquine led to significant lesion flattening and repression.
- Previously refractory skin lesions showed a favorable response to the treatment regimen.
Conclusions:
- Isotretinoin can be an effective therapeutic option for recalcitrant hypertrophic lupus erythematosus.
- Accurate diagnosis and consistent follow-up are crucial for managing HLE.
- Early and adequate treatment may prevent complications such as squamous cell carcinoma.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Nephrotic Syndrome I : Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Nephrotic Syndrome II : Assessment and Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
